Sylentis

10 articles about Sylentis

• Sylentis announces results of Phase 3 HELIX trial with tivanisiran for the treatment of Dry Eye Disease

  1/31/2019

  Sylentis, a PharmaMar Group company (MSE:PHM), has announced today the results of the HELIX [i]exploratory clinical trial; a Phase 3 efficacy and safety study with tivanisiran compared against artificial tears for the treatment of dry eye disease

• Sylentis, PharmaMar Group, Announces the End of Patient Recruitment for its HELIX Trial

  10/19/2018

  Sylentis has reached the target of recruiting patients for its Phase III trial "HELIX" for the treatment of the signs and symptoms of dry eye disease

• Sylentis Presented New Results for the Treatment of Age Associated Macular Degeneration

  5/4/2018

  Topical administration of siRNA could be a new therapeutic option for the treatment of degenerative illnesses of the retina that presents processes of neovascularization[i].

• Sylentis Announces the Clinical Results of Tivanisiran for the Treatment of Dry Eye Syndrome

  5/3/2018

  The studies carried out with tivanisiran showed an improvement in the inflammatory ocular parameters, tear quality, and a reduction in ocular pain, that is associated with dry eye syndrome[i]

• Sylentis Presents New Results on Its Ophthalmological Compounds at ARVO 2018

  4/26/2018

  Sylentis Presents New Results on Its Ophthalmological Compounds at ARVO 2018

• PharmaMar: Sylentis Presents New Data On A New Eye Drop siRNA For The Treatment Of Retinal Diseases Avoiding Intraocular Injections

  9/26/2017

• Sylentis Initiates A Phase III Study For The Treatment Of Dry Eye Syndrome

  6/1/2017

• Sylentis Reports Positive Phase II Results With SYL1001 In Treating Ocular Pain Related To Dry Eye Syndrome

  3/14/2016

• Alnylam Pharmaceuticals Grants InterfeRx™ Intellectual Property License to Sylentis for Development and Commercialization of RNAi Therapeutics

  11/17/2011

• Sylentis Receives Authorization to Commence a New Phase I/II Clinical Trial with SYL040012 for Treating Elevated Intraocular Pressure and Glaucoma

  9/8/2010